Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Cover image for Vol. 38 Issue 2

Edited By: C. Lindsay DeVane, Pharm.D., FCCP, BCPP

Impact Factor: 2.932

ISI Journal Citation Reports © Ranking: 2016: 95/257 (Pharmacology & Pharmacy)

Online ISSN: 1875-9114

Associated Title(s): JACCP: Journal of the American College of Clinical Pharmacy

Antithrombotic Virtual Issue

Welcome to Pharmacotherapy’s themed issue on antithrombotic therapy!

Antithtrombotic therapy has significantly evolved in the last decade. While newer agents have emerged, older agents have not lost their utility. This virtual issue is a compilation of important articles focusing on the utility, safety, efficacy, and monitoring of anticoagulant and antiplatelet agents in various clinical scenarios.

Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation
Beenish S. Manzoor, Todd A. Lee, et al

Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics
Insaf Mohammad, Bianca Korkis, et al

Warfarin Pharmacogenomics in Diverse Populations
Justin B. Kaye, Lauren E. Schultz, et al

Comparative Effectiveness of Oral Antiplatelet Agents in Patients with Acute Coronary Syndrome
Kibum Kim, Todd A. Lee, et al

Anticoagulation Bridge Therapy in Patients with Atrial Fibrillation: Recent Updates Providing a Rebalance of Risk and Benefit
Candice L. Garwood, Bianca Korkis, et al

Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications
Catherine K. Floroff, Nicole M. Palm, et al

Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment
Brooke E. Stanton, Naomi S. Barasch, et al

Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know
Susan E. Conway, Andrew Y. Hwang, et al

Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital
Nicole E. Cieri, Kristen Kusmierski, et al